A key factor in the success and sustainability of SEAM Program initiatives is our ongoing collaboration with other global initiatives supported by the Bill & Melinda Gates Foundation.

SEAM is able to respond to requests from leaders of collaborating initiatives to provide technical assistance in incorporating appropriate pharmaceutical management initiatives into their programs.

Many of these collaborating organizations address the world's most pervasive and deadly diseases, including HIV/AIDS, malaria, and tuberculosis.

HIV/AIDS

SEAM works in support of the United Nations Programme on HIV/AIDS (UNAIDS) and other HIV/AIDS initiatives.

Malaria

SEAM supports initiatives to improve access to antimalarials and bed nets, especially for poor households. SEAM staff use their experience in logistics management to ensure that country initiatives against malaria provide practical solutions for the treatment of women and children, who are most at risk of dying.

Tuberculosis

SEAM provides technical support to Global Drug Facility (GDF), an international program working to eliminate tuberculosis (TB) as a killer disease in countries with poor access to effective, high-quality TB treatment drugs. SEAM helps the GDF develop mechanisms to procure TB drugs for poor countries that are willing and able to implement the Directly Observed Treatment, Short-course (DOTS) strategy, which is highly effective in treating the disease and controlling its spread.

To further help the GDF meet its objective of controlling TB, SEAM and Rational Pharmaceutical Management Plus (RPM Plus) worked with Stop TB and the Royal Netherlands Tuberculosis Association (KNCV) to organize a meeting on Improving TB Drug Management, June 6-8, 2002, in Washington, D.C.

SEAM's work with other partners, including the RPM Plus Program funded by the U.S. Agency for International Development (USAID), strengthens systems of TB drug management at the country level so that drugs procured under the GDF reliably reach patients in need.